TiterMax® Gold Adjuvant
SIGMA/T2684 - liquid
MDL Number: MFCD01095344
Product Type: Chemical
| availability | not available in Japan |
| conjugate | unconjugated |
| form | liquid |
| Quality Level | 100  |
| storage temp. | 2-8°C |
| Application: | TiterMax® Gold Adjuvant has been used: • to emulsify soluble antigen-1 (Ag-1) to immunize animals to generate fully human monoclonal antibodies from XenoMouse strains • to inject GST-dGIPC (Drosophila homolog of GAIP interacting protein) protein into rats for generating antibodies against dGIPC protein • with Drosophila CtBP (dCtBP) protein in phosphate-buffered saline (PBS) to subcutaneously inject in a New Zealand female rabbit |
| Biochem/physiol Actions: | Specific proteins can be emulsified with equal volume of TiterMax® Gold Adjuvant to immunize lab animals and extract antibodies from them. |
| Biochem/physiol Actions: | TiterMax Gold is a new and improved water-in-oil adjuvant. By developing a new block copolymer and eliminating the silica from the formulation, TiterMax Gold appears to be less toxic and more effective than TiterMax Classic. The optimum volume of TiterMax Gold for an emulsion is twice that of TiterMax Classic. |
| Disclaimer: | Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals. |
| General description: | TiterMax Gold Adjuvant contains three essential ingredients: a new block copolymer, CRL-8300, squalene (a metabolizable oil) and a sorbitan monooleate. |
| Legal Information: | TiterMax is a registered trademark of TiterMax USA, Inc |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352203 |